載入...
P04.18 Response assessment of bevacizumab for malignant glioma <: > comparison between PET and pathological studies
Introduction: Diagnostic imaging such as magnetic resonance imaging (MRI) is the most commonly used morphological method for determination of size and location of brain tumors. However, it is difficult to evaluate the effect of bevacizumab for malignant gliomas by using only MRI. In contrast, positr...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464278/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.158 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|